Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Falling Comet
187.3800 4.56 (2.49%)
NSE Dec 22, 2025 15:31 PM
Volume: 491.6K
 

187.38
2.49%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Number of FII/FPI investors decreased from 159 to 146 in Sep 2025 qtr
More from Marksans Pharma Ltd.
Recommended